The Different Stages in Clinical Trials

Ever wonder how treatments become available? Have you heard about “phases” of development and FDA approval? Here’s a primer on how treatments get to those who can benefit from them.

Insulin Delivery

For people with Type 1 diabetes and in some cases those with Type 2 diabetes, insulin must be injected and infused into the layers of fat under the skin. There are quite a few different ways to deliver insulin, each with pros and cons, and it is up to the person with Type 1 and his or her doctor to decide what will work best.

Insulin Pump Rundown

Choosing an insulin pump doesn’t have to be an overwhelming process. Should you go with a more traditional pump where you can monitor your insulin levels directly? Are you looking for a model that works with a BGM monitor and allows you to administer insulin via a remote?

JDRF Launches Center of Excellence to Accelerate Cure for Type 1 Diabetes

On September 4, JDRF announced the launch of its Northern California Center of Excellence, dedicated to focused efforts on research and breakthroughs to cure Type 1 diabetes.

Becoming Visible: Lisa Hepner’s Journey With ‘The Human Trial’

Craig Stubing had the chance to discuss Type 1 with Lisa Hepner, director of the Human Trial.

T1D Exchange and Tidepool Partner with Beyond Type 1 to Study Athletes with Type 1 Diabetes 

Beyond Type 1 announces collaborative research study produced with T1DExchange + Tidepool, focusing on glycemic variability and exercise.

My Journey with Hypo Anxiety

Kristi shares the story of her anxiety surrounding hypoglycemia, how she came to name the issue and how she has grown in the face of adversity.

Nasal Glucagon Baqsimi Approved by the FDA

On Thursday, the Food and Drug Administration approved Eli Lilly and Company's Baqsimi, a non-injectable, nasal glucagon and the first of its kind.

Find The Devices You Need: DiabetesWise

DiabetesWise is dedicated to helping those living with diabetes discover the best devices to live their desired lifestyle.

JDRF Advocates Urge Congress to Renew Funding for T1D Research

On the final day of the 2019 JDRF Children's Congress, advocates implored the U.S. Special Committee on Aging to renew the Special Diabetes Program.

What is Hypoglycemia Unawareness? (Unabridged)

The unabridged version of the amazing scientific lowdown on hypoglycemia unawareness and understanding its importance written by Jordan Hoese, MD, MPH.

One on One With Insulet CEO Shacey Petrovic

Insulet CEO Shacey Petrovic spoke with Beyond Type 1 about her personal connection to T1D, the importance of access, the future of Omnipod and more.

What is Hypoglycemia Unawareness?

Jordan Hoese, MD, MPH gives us the scientific lowdown on hypoglycemia unawareness and why it's crucial to understand this common diabetes complication.

ADA 2019 in Review

Beyond Type 1's editorial staff reflects on the highlights, lowlights, insights, and biggest takeaways from the biggest diabetes conference of the year.

FDA Approves First Ready-to-Use Liquid Stable Glucagon Gvoke

On September 10 the FDA approved the Gvoke HypoPen and Gvoke PFS, emergency glucagon rescue devices for the treatment of severe hypoglycemia.